BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 2447700)

  • 1. Induction of an antiviral state by interferon in the absence of elevated levels of 2,5-oligo(A) synthetase and eIF-2 kinase.
    Lewis JA
    Virology; 1988 Jan; 162(1):118-27. PubMed ID: 2447700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon action in human fibroblasts: induction of 2', 5'-oligoadenylate synthetase in the absence of detectable protein kinase activity.
    Holmes SL; Gupta SL
    Arch Virol; 1982; 72(1-2):137-42. PubMed ID: 6179503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral actions of interferon. Interferon-regulated cellular proteins and their surprisingly selective antiviral activities.
    Samuel CE
    Virology; 1991 Jul; 183(1):1-11. PubMed ID: 1711253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of anti-viral activity and specific enzymes in cell-lines derived from interferon-resistant, thymidine kinase deficient mouse L-929 cells.
    Lewis JA
    Prog Clin Biol Res; 1985; 202():325-32. PubMed ID: 2421311
    [No Abstract]   [Full Text] [Related]  

  • 5. Lack of systematic correlation between the interferon mediated antiviral state and the levels of 2-5A synthetase and protein kinase in three different types of murine cells.
    Hovanessian AG; Meurs E; Montagnier L
    J Interferon Res; 1981 Feb; 1(2):179-90. PubMed ID: 6286803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta and gamma interferons act synergistically to produce an antiviral state in cells resistant to both interferons individually.
    Lewis JA; Huq A; Shan B
    J Virol; 1989 Nov; 63(11):4569-78. PubMed ID: 2552141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-mediated antiviral state in human MRC5 cells in the absence of detectable levels of 2-5A synthetase and protein kinase.
    Meurs E; Hovanessian AG; Montagnier L
    J Interferon Res; 1981 Feb; 1(2):219-32. PubMed ID: 6180053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the role of the 2'-5'-oligoadenylate synthetase-RNase L pathway in beta interferon-mediated inhibition of encephalomyocarditis virus replication.
    Kumar R; Choubey D; Lengyel P; Sen GC
    J Virol; 1988 Sep; 62(9):3175-81. PubMed ID: 2841470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymidine kinase genes and the induction of anti-viral responses by interferon.
    Mengheri E; Esteban M; Lewis JA
    FEBS Lett; 1983 Jul; 157(2):301-5. PubMed ID: 6190677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of interferon on sensitive and resistant L1210 cell lines.
    Marti J; Vandenbussche P; Silhol M; Milhaud P; Verhaegen M; Content J; Lebleu B
    J Interferon Res; 1981 Feb; 1(2):287-95. PubMed ID: 6180059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-induced and double-stranded RNA-activated enzymes: a specific protein kinase and 2',5'-oligoadenylate synthetases.
    Hovanessian AG
    J Interferon Res; 1991 Aug; 11(4):199-205. PubMed ID: 1717615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of MuIFN-alpha/beta and MuIFN-gamma-induced antiviral states: differential effects with different challenge viruses and lack of correlation with 2'5' oligoadenylate synthetase levels.
    Ramamurthy V; Fleischmann WR
    J Biol Regul Homeost Agents; 1988; 2(1):7-14. PubMed ID: 2845725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral activity of tumour necrosis factor. Synergism with interferons and induction of oligo-2',5'-adenylate synthetase.
    Mestan J; Brockhaus M; Kirchner H; Jacobsen H
    J Gen Virol; 1988 Dec; 69 ( Pt 12)():3113-20. PubMed ID: 2462015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of antiviral action of interferon.
    Baglioni C; Nilsen TW
    Interferon; 1983; 5():23-42. PubMed ID: 6202642
    [No Abstract]   [Full Text] [Related]  

  • 15. Induction of an anti-viral response and 2',5'-oligo A synthetase by interferon in several thymidine kinase-deficient cell lines.
    Lewis JA; Esteban M
    Virology; 1984 Mar; 133(2):464-9. PubMed ID: 6324463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive expression of (2'-5') oligo A synthetase confers resistance to picornavirus infection.
    Chebath J; Benech P; Revel M; Vigneron M
    Nature; 1987 Dec 10-16; 330(6148):587-8. PubMed ID: 2825034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical pathways in interferon-action.
    Sen GC
    Pharmacol Ther; 1984; 24(2):235-57. PubMed ID: 6205407
    [No Abstract]   [Full Text] [Related]  

  • 18. Differential antiviral effects of interferon in three murine cell lines.
    Sen GC; Herz RE
    J Virol; 1983 Mar; 45(3):1017-27. PubMed ID: 6187940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral, anticellular and enzyme-inducing activities of interferons in RD-114 cells.
    Sen GC; Herz RE; Rubin BY
    J Gen Virol; 1983 Oct; 64 (Pt 10)():2213-20. PubMed ID: 6194249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative studies on (2'-5')oligoadenylate-related enzyme systems and the antiviral effect of interferon in two mouse cell lines which differ in (2'-5')oligoadenylate sensitivity of their protein synthesizing system.
    Taira H; Yamamoto F; Furusawa M; Sawai H; Kawakita M
    J Interferon Res; 1985; 5(4):583-96. PubMed ID: 2418128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.